Perimeter Medical Imaging AI, Inc. Stock Deutsche Boerse AG

Equities

4PC

CA71385D1078

Advanced Medical Equipment & Technology

Market Closed - Deutsche Boerse AG 02:10:50 2024-05-28 am EDT 5-day change 1st Jan Change
0.368 EUR +5.75% Intraday chart for Perimeter Medical Imaging AI, Inc. 0.00% -54.29%

Financials

Sales 2024 * 1.09M 800K 737K Sales 2025 * 2.46M 1.8M 1.66M Capitalization 36.43M 26.69M 24.6M
Net income 2024 * -28M -20.51M -18.91M Net income 2025 * -27M -19.78M -18.23M EV / Sales 2024 * 33.4 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 14.8 x
P/E ratio 2024 *
-1.24 x
P/E ratio 2025 *
-1.28 x
Employees 43
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.37%
More Fundamentals * Assessed data
Dynamic Chart
Perimeter Medical Imaging AI Reports First Quarter 2024 Financial Results MT
Transcript : Perimeter Medical Imaging AI, Inc., Q1 2024 Earnings Call, May 14, 2024
Perimeter Medical Imaging AI, Inc.(TSXV:PINK) dropped from S&P/TSX Venture Composite Index CI
Transcript : Perimeter Medical Imaging AI, Inc. - Special Call
Perimeter Medical Imaging AI to Participate at Annual Meeting of the American Society of Breast Surgeons MT
Perimeter Medical Imaging AI, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Transcript : Perimeter Medical Imaging AI, Inc., Q4 2023 Earnings Call, Mar 28, 2024
Perimeter Medical Imaging AI Provides Corporate Update On Grant Funding Opportunities MT
Perimeter Medical Imaging AI, Inc. Announces Results from New Study 1 Published in the Annals of Surgical Oncology CI
Perimeter Medical Imaging AI Provides Update MT
Perimeter Medical Imaging AI, Inc. Announces Expanded Commercial Presence Within National Healthcare Provider System with Follow-On Placement of Perimeter S-Series Oct At Additional Hospital Site CI
Perimeter Medical Imaging AI Announces Further Commercial Expansion in North Texas MT
Transcript : Perimeter Medical Imaging AI, Inc. - Shareholder/Analyst Call
Transcript : Perimeter Medical Imaging AI, Inc. - Special Call
Perimeter Medical Imaging AI, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
More news

Latest transcript on Perimeter Medical Imaging AI, Inc.

1 day+5.75%
Current month-4.66%
1 month-20.00%
3 months-43.82%
6 months-30.57%
Current year-54.29%
More quotes
1 week
0.34
Extreme 0.342
0.37
1 month
0.30
Extreme 0.298
0.47
Current year
0.30
Extreme 0.298
0.84
1 year
0.30
Extreme 0.298
1.31
3 years
0.30
Extreme 0.298
3.50
5 years
0.30
Extreme 0.298
3.50
10 years
0.30
Extreme 0.298
3.50
More quotes
Managers TitleAgeSince
Chief Executive Officer - 23-06-04
Founder - 13-05-15
Director of Finance/CFO - 23-08-31
Members of the board TitleAgeSince
Director/Board Member - 17-03-31
Director/Board Member 55 20-08-25
Director/Board Member 48 20-07-02
More insiders
Date Price Change
24-05-28 0.368 +5.75%
24-05-27 0.348 -3.87%
24-05-24 0.362 +5.85%
24-05-23 0.342 -1.72%
24-05-22 0.348 -5.43%

Delayed Quote Deutsche Boerse AG, May 28, 2024 at 02:10 am EDT

More quotes
Perimeter Medical Imaging AI, Inc. is a medical technology company driven to transform cancer surgery with resolution, real-time, imaging tools to address high unmet medical needs. It develops and commercializes in-procedural medical imaging tools. The Company’s Perimeter Optical Coherence Tomography (OCT) system, which provides cross-sectional, real-time margin visualization of tissue microstructures during surgical procedures. The Perimeter S-Series OCT is designed to provide surgeons with the clinical support they need in the OR. The OCT medical imaging system includes an intraoperative device for automated scanning of a tissue specimen that provides a rapid subsurface map of up to a 10 cm by 10 cm surface area; a specimen-handling consumable designed to hold and maintain orientation of the specimen, and an image library and training set. Its machine learning tools and artificial intelligence technology, called ImgAssist AI, through clinical development under its ATLAS AI project.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
0.54 CAD
Average target price
3.875 CAD
Spread / Average Target
+617.59%
Consensus